Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Classen Immunotherapies, Inc. v. Somaxon Pharmaceuticals, No. 13-1405 (Fed. Cir. Jan. 17, 2014)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 13-1405
Decided
January 17, 2014
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit CLASSEN IMMUNOTHERAPIES, INC.,

Plaintiff-Appellant,

v.

SOMAXON PHARMACEUTICALS,

Defendant-Appellee.

2013-1405

Appeal from the United States District Court for the Central District of California in No. 12-CV-6643, Judge Gary Feess.

JUDGMENT

JOSEPH J. ZITO, DNL ZITO, of Washington, DC, argued for plaintiff-appellant. With him on the brief was BENJAMIN C. DEMING, of Los Angeles, California.

LISA J. PIROZZOLO, Wilmer Cutler Pickering Hale and Dorr, LLP, of Boston, Massachusetts, argued for defendant-appellee. With her on the brief were MARK C. FLEMING, and DAVID A. MANSPEIZER, of New York, New York.

2THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT January 17, 2014 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Classen Immunotherapies, Inc. v. Somaxon Pharmaceuticals, No. 13-1405 (Fed. Cir. Jan. 17, 2014).

govinfo ID
USCOURTS-ca13-13-01405-0
Permalink
https://patentcasewatch.com/opinions/USCOURTS-ca13-13-01405-0

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.